NSC 405020

CAS No. 7497-07-6

NSC 405020( NSC-405020 | NSC 405020 | NSC405020 )

Catalog No. M15856 CAS No. 7497-07-6

NSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 57 In Stock
25MG 114 In Stock
100MG 325 In Stock
200MG 491 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC 405020
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.
  • Description
    NSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-405020 | NSC 405020 | NSC405020
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MT1-MMP
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    7497-07-6
  • Formula Weight
    260.16
  • Molecular Formula
    C12H15Cl2NO
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 52 mg/mL (199.87 mM); DMSO: 52 mg/mL (199.87 mM)
  • SMILES
    O=C(NC(C)CCC)C1=CC=C(Cl)C(Cl)=C1
  • Chemical Name
    3,4-Dichloro-N-(1-methylbutyl)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Remacle AG, et al. Y Res. 2012 May 1;72(9):2339-49.
molnova catalog
related products
  • Fraxinellone

    Fraxinellone significantly reduced weight loss and diarrhea in mice and alleviated the macroscopic and microscopic signs of the disease.

  • 4',6,7-Trimethoxyiso...

    4',6,7-Trimethoxyisoflavone promotes wound healing through NOX2 induction, which leads to collective migration and MMP activation.

  • Cipemastat

    Cipemastat (Ro 32-3555) is a potent, second-generation, orally active MMP inhibitor.